Browsing: highlights

New York, USA, August 16, 2026 — International Relaxation Day highlights the growing importance of personal well-being, encouraging people to create moments of balance, comfort, and self-connection amid increasingly fast-paced lifestyles. In recognition of the occasion, intimate apparel brand AVIDLOVE is sharing its perspective on how thoughtful design and comfortable fabrics can support everyday relaxation…

For Immediate Release:August 14, 2026Office of the Governor Contact:press@governor.virginia.gov

OHS, DPH Highlights Delaware’s Groundbreaking Prehospital Whole Blood Program in New Ambassador of Safety Video – State of Delaware News

From strengthening maternal and child health research to developing statewide data tools and informing national rural health policy, East Tennessee State University’s Center for Rural Health and Research continues to expand its impact across Appalachia and beyond

Fractyl HealthGUTSsaid its Revita endoscopic procedure showed durable weight-maintenance results one year after patients discontinued GLP-1 therapy, while the company reaffirmed plans to report pivotal trial data in early fourth-quarter 2026 and pursue a potential FDA De Novo submission later in the year

MedPal AI plc (AIM: MPAL)has highlighted the UK approval of Eli Lilly’s once-daily oral GLP-1 treatment, Foundayo, which has been authorised for weight loss and weight maintenance in eligible adults

Weak second-quarter performance led Xponential Fitness to lower its 2026 outlook. North American same-store sales fell 6.8%, revenue declined 13% to $66 million, and adjusted EBITDA dropped 22% to $21.9 million

PerrigoPRGOreported second-quarter 2026 results that exceeded its internal earnings expectations, while sales declined amid soft consumer self-care categories, retailer inventory reductions and a slower start to seasonal demand. The company maintained its full-year outlook, citing improving category trends, market-share gains and expected second-half contributions from innovation, distribution and demand-generation efforts

Novo Nordisk A/SNVOreported second-quarter adjusted sales growth of 7% at constant exchange rates, supported by GLP-1 volume growth across its obesity and diabetes franchises, while lower realized prices and manufacturing-related costs weighed on margins

DoximityDOCSreported fiscal 2027 first-quarter revenue of $157 million, up 7% from a year earlier, as the company cited improving demand from pharmaceutical and hospital customers and increased engagement with its clinical artificial intelligence tools